IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q3 2022 Holdings

Filed 2022-10-21 | 10 holdings | $1.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$1.7M230,00097.4%
Utah MED Prods Inc(UTMD)COM917488108$7.3K86,0000.4%
Bristol-Myers Squibb Co(BMY)COM110122108$7.0K98,0000.4%
Gilead Sciences Inc(GILD)COM375558103$6.5K105,0000.4%
Cigna Corp New(CI)COM125523100$4.7K17,0000.3%
Kempharm Inc(ZVRA)COM NEW488445206$4.7K750,0000.3%
Cardinal Health Inc(CAH)COM14149Y108$4.7K70,0000.3%
Mckesson Corp(MCK)COM58155Q103$4.4K13,0000.2%
Viatris Inc(VTRS)COM92556V106$4.1K480,0000.2%
Opiant Pharmaceuticals IncCOM683750103$2.3K210,0000.1%